z-logo
Premium
Development and optimization of a sensitive TaqMan® real‐time PCR with synthetic homologous extrinsic control for quantitation of Human cytomegalovirus viral load
Author(s) -
Slavov Svetoslav Nanev,
Otaguiri Katia Kaori,
de Figueiredo Glauciane Garcia,
Yamamoto Aparecida Yulie,
MussiPinhata Marisa Marcia,
Kashima Simone,
Covas Dimas Tadeu
Publication year - 2016
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.24499
Subject(s) - human cytomegalovirus , taqman , virology , biology , real time polymerase chain reaction , viral load , polymerase chain reaction , betaherpesvirinae , population , plasmid , virus , herpesviridae , viral disease , gene , medicine , genetics , environmental health
Human cytomegalovirus ( Human herpesvirus 5 , HCMV) causes frequent asymptomatic infections in the general population. However, in immunosuppressed patients or congenitally infected infants, HCMV is related to high morbidity and mortality. In such cases, a rapid viral detection is crucial for monitoring the clinical outcome and the antiviral treatment. In this study, we optimized a sensitive biplex TaqMan® real‐time PCR for the simultaneous detection and differentiation of a partial HCMV UL97 sequence and homologous extrinsic control (HEC) in the same tube. HEC was represented by a plasmid containing a modified HCMV sequence retaining the original primer binding sites, while the probe sequence was substituted by a phylogenetically divergent one (chloroplast CF 0 subunit plant gene). It was estimated that the optimal HEC concentration, which did not influence the HCMV amplification is 1,000 copies/reaction. The optimized TaqMan® PCR demonstrated high analytical sensitivity (6.97 copies/reaction, CI = 95%) and specificity (100%). Moreover, the reaction showed adequate precision (repeatability, CV = 0.03; reproducibility, CV = 0.0027) and robustness (no carry‐over or cross‐contamination). The diagnostic sensitivity (100%) and specificity (97.8%) were adequate for the clinical application of the molecular platform. The optimized TaqMan® real‐time PCR is suitable for HCMV detection and quantitation in predisposed patients and monitoring of the applied antiviral therapy. J. Med. Virol. 88:1604–1612, 2016 . © 2016 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom